Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $226K | — | — | — | $0.00 | $0.00 |
| Operating income | -$8.33M | -$35.8M | -$67.6M | -$78.2M | -$62.4M | -$79.5M |
| Operating margin | -3685.8% | — | — | — | — | — |
| Net income | -$8.28M | -$35.5M | -$63.3M | -$66.9M | -$49.6M | -$69.8M |
| Net margin | -3663.7% | — | — | — | — | — |
| EPS (diluted) | -$0.52 | -$0.77 | -$1.14 | -$1.19 | -$0.88 | -$1.22 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$8.67M | -$29.4M | -$51.3M | -$58.6M | -$43.1M | -$54.4M |
| Capital expenditures | $76.0K | $1.54M | $918K | $256K | $340K | $193K |
| Free cash flow | -$8.74M | -$30.9M | -$52.2M | -$58.8M | -$43.4M | -$54.6M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.38M | $299M | $26.5M | $21.2M | $22.6M | $16.9M |
| Total assets | $36.5M | $391M | $341M | $290M | $252M | $226M |
| Total liabilities | $2.48M | $8.43M | $13.8M | $12.0M | $10.00M | $13.7M |
| Shareholders' equity | -$11.3M | $382M | $327M | $278M | $242M | $213M |
| Retained earnings | -$11.9M | -$47.5M | -$111M | -$178M | -$227M | -$297M |
| Shares (wtd avg diluted) | 16.0M | 45.9M | 55.7M | 56.0M | 56.6M | 57.3M |
Every figure is extracted from Design Therapeutics, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.